To Evaluate Effects of AZD1446, Placebo and Donepezil in Patients With Alzheimer's Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The purpose of this study is to evaluate whether treatment with single and multiple oral doses of AZD1446 for 1 week will have effect on Quantified Electroencephalography and Event-Related Potentials in patients with Alzheimers Disease. The total treatment period is 9 weeks, divided into 5 equally long sub-periods of 7 days and 4 wash-out periods of 7 days each.
Epistemonikos ID: 58c79ee2c3bb0d0da350462250d3e8a3d69f3606
First added on: May 05, 2024